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Background: The Solomon Islands is targeting elimination of malaria by 2030. The dominant vector is the pre-
dominantly exophagic, exophilic Anopheles farauti sensu strictu. This biting behaviour limits the efﬁcacy of con-
ventional vector control tools and highlights the need for new strategies. When administered to humans
ivermectin has been shown to have a mosquitocidal effect. Mass drug administration (MDA) with ivermectin is
an emerging strategy in the control of scabies. In this study we explored any incidental effect of ivermectin
MDA conducted for scabies control on mosquitoes.
Methods: MDA for scabies was conducted in three villages. We performed human landing catches and mea-
sured 5-day mortality amongst Anopheles mosquitoes caught before and after MDA. Cox regression was used
to calculate hazard ratios (HR) for mortality between mosquitoes caught before and after MDA.
Results: There was a signiﬁcant increase in 5-day mortality in anopheline mosquitoes caught post-MDA which
was highest on the day of MDA itself (HR 4.2 95% CI 1.8 to 10.1, p=0.001) and the following day (HR 4.4 95% CI
1.8 to 10.8, p=0.002) compared to mosquitoes caught before MDA.
Conclusions: This study shows a possible mosquitocidal effect of ivermectin MDA conducted for scabies con-
trol. Studies with a larger sample size with clinical as well as entomological outcomes should be conducted in
this population.
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Introduction
WHO has set an ambitious goal to eliminate malaria from 35
countries by the year 2030.1 The Solomon Islands is one of the
countries targeted by WHO for malaria elimination. The country
is an archipelago, consisting of approximately 1000 islands, with
a population of approximately 500 000.2 In 2014 the rate of
conﬁrmed cases of malaria was 44 per 1000 person years.3
Malaria has been reported to have declined as a cause of fever
in some parts of the Solomon Islands in the last ten years4 but
remains an important public health problem.
Prior to the Malaria Eradication Programme (MEP) in the
1970s three species of Anopheles mosquitoes were involved in
the transmission of malaria in the Solomon Islands. Anopheles
koliensis, Anopheles punctulatus and Anopheles farauti sensu
strictu. The MEP was based predominantly on a strategy of
indoor residual spraying (IRS) combined with mass drug admin-
istration.5 An. koliensis appears to have been eliminated follow-
ing the MEP and An. punctulatus is no longer considered a major
vector having been controlled through the use of IRS and
long-lasting insecticide treated bed nets (LLINs) in the 1990s.6
An. farauti s.s. is now considered to be the dominant vector for
malaria in the Solomon Islands.7 Compared to An. gambiae,
An. farauti is a relatively ineffective vector, with a relatively short
life span and indiscriminate host preference, which results in
highly variable rates of human biting.8–10
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The selective pressure exerted by the MEP resulted in a new
behavioural pattern of An. farauti s.s. This species now feeds
and rests predominantly outdoors and has peak biting activity
outside sleeping hours,11,12 which reduces the efﬁcacy of IRS
and LLINs13 as methods of vector control. New vector control
tools might be required to achieve the 2030 elimination target.
There is increasing interest in the potential role of ivermectin
as a complementary tool to reduce malaria transmission.14,15
The drug reduces the survival of insectary-bred anophelines
that feed on volunteers, and those caught in the wild including
An. farauti.15,16 This effect is mediated by antagonism of mos-
quito glutamate-gated chloride channels resulting in ﬂaccid par-
alysis and death.14 A small number of studies have also
assessed the incidental effect of ivermectin mass drug adminis-
tration (MDA) conducted for both lymphatic ﬁlariasis and oncho-
cerciasis on local mosquito populations. These studies have
shown increased mortality amongst African malaria vectors17–19
but few similar ﬁeld studies have been conducted in the Paciﬁc
region20 and none directly assessing An. farauti s.s.
Ivermectin is also emerging as a key tool in the control of sca-
bies. MDA with ivermectin has been shown to have a dramatic
effect on the prevalence of scabies.21 The Paciﬁc region is a particu-
lar focus for scabies worldwide22–24 and a number of large scale
evaluations of ivermectin MDA are either underway or planned in
the region. Given the biting habits of An. farauti s.s., ivermectin MDA
might be of use in the region as a complementary vector control
tool.
Given the high prevalence of scabies in the Solomon Islands
and the 2030 malaria elimination target there are important
potential synergies between the NTD and malaria control pro-
grammes. This study was conducted to assess whether iver-
mectin MDA conducted for the purposes of scabies control
could have an incidental mosquitocidal effect on An. farauti s.s.
and other local malaria vectors.
Methods
Study site
The study was conducted in communities in the East Kwaio
region of the Solomon Islands. Three communities located in
Uru Harbour were selected to participate in this study due to
their involvement in the scabies intervention study that was
being conducted in these communities. The three communities
were all located within 750 m of each other and were con-
sidered as a single site for the purpose of this study. All villages
were located in a coastal region where An. farauti s.s. is known
to be the dominant anopheline mosquito.
Mass drug administration
This entomological survey ran alongside a scabies intervention
study [ClinicalTrials.gov identiﬁer: NCT02775617]. Brieﬂy, MDA
with single dose ivermectin (200 μg/kg) was conducted between
the hours of 10:00 h and 18:00 h as previously described.21 All
individuals in the village were invited to participate, including
the human landing catchers (HLC). Pregnant and breastfeeding
women and children weighing less than 15 kg were excluded
from ivermectin mass treatment in line with treatment guidelines.
The MDA achieved 80% coverage. For the purpose of this study,
the day that MDA was conducted was considered as day 1 for
ivermectin exposure.
Field work
Adult volunteers (aged>18 years) to perform the human landing
catches were enrolled from the local communities. Volunteers
were split into two groups (four pairs and one group of three). A
member of the study team (CK) trained volunteers to perform
human landing catches as previously described25–27 and in line
with WHO 2013 guidelines for entomological and vector control
participants.28 Catches were supervised by a member of the study
team (CK). Brieﬂy each individual was provided with a mouth
aspirator, head torch and a net covered cup for collecting mosqui-
toes. Each of the catchers received their dose of ivermectin at the
same time, around 16:00 h. Volunteers were spread out across
the communities and performed catches outdoors under an open
wooden roof in front of the houses. To avoid bias the same sites
were used for human landing catches on each day of the study.
In line with the known biting habits of An. farauti s.s. from other
sites. Catching was performed between 18:00 h−23:00 h.12
Volunteers were checked for fever routinely during the study per-
iod and for a two-week observation following the ﬁnal landing
catch. At the end of the observation period all individuals were
offered a rapid diagnostic test for malaria (CareStart Malaria,
Access Bio, Somerset, New Jersey, USA). Individuals who had a
positive rapid diagnostic test were provided with a full treatment
course of arthemeter-lumefantrine free of charge.
All mosquitoes caught were stored in a central room with
screened open windows to guarantee equal humidity and tempera-
ture between the room and the environment, and nutrition was
maintained with cotton wool pads impregnated with a 10% sugar
solution that was exchanged daily. Partially engorged and unfed
mosquitoes were not discarded and were included in the analysis.
Collections took place for 4 consecutive days (1 day before
MDA and the 3 subsequent days). This duration was selected
based on the half-life of ivermectin as the plasma level falls
below the level which is felt to be mosquitocidal after 3 days.
Each collection was reviewed daily at 23:30 h. Dead mosquitoes
were separated from live mosquitoes. Identiﬁcation of the dead
mosquitoes was performed the subsequent day. Identiﬁcation
was based on direct visual inspection and magniﬁed inspection
using an Olympus X31 microscope (Olympus, Tokyo, Japan) at
X40 magniﬁcation. Mosquitoes were classiﬁed as Anopheles or
Culex. Although there are other Anopheles species that bite
humans in the Solomon Islands, An. farauti s.s. is the only
coastal dwelling and brackwater breeding anopheline mosquito
biting humans in the Solomon Islands. The other species do not
share this speciﬁc biological niche with An. farauti s.s.10 there-
fore, it was expected that the anophelines caught would be An.
farauti s.s.,29 but PCR for speciation was not performed.
Statistics
The primary endpoint of the study was the 5-day mortality of
Anopheles species mosquitoes. For the purposes of analysis, we
pooled mosquitoes caught across the three communities each
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day. Based on previous data on the effect of ivermectin on mos-
quitoes we aimed to compare mortality in mosquitoes caught
before MDA and up to 3 days after MDA. Based on existing data
the predicted 5-day mortality of mosquitoes caught pre-MDA
was expected to be 20% while that of mosquitoes caught on
the ﬁrst days after MDA was expected to be close to 70%.18,30
Based on these data we calculated that at least 19 anopheline
mosquitoes were required per night across all HLCs combined in
order to have 90% power to detect this difference. Kaplan-Maier
curves were constructed and Cox regression was used to calcu-
late hazard ratios for 5-day mortality for mosquitoes caught
before ivermectin MDA and on the 3days following MDA. The
analysis was performed in STATA 13.1 (Statacorp, College
Station, Texas, USA).
Study ethics
Individuals performing human landing catches provided
informed written consent to participate in the study. HLC volun-
teers did not receive prophylaxis, as studies have shown that
they are not at a higher risk of acquiring malaria compared to
the general population.25
Results
A total of eleven male volunteers (median age 38, IQR 30–44)
were enrolled in the study to perform the landing catches. Ten
of the individuals were asymptomatic throughout the study per-
iod and the subsequent 2-week observation period. All had a
negative malaria rapid diagnostic test. One individual was
asymptomatic but his rapid diagnostic test was positive for
Plasmodium falciparum HRP2 and he was treated with a full
course of arthemeter-lumefantrine, and was well at 1 week
follow-up.
A total of 110 mosquitoes were caught pre-MDA across the
three communities of which 24 (21.8%) were anopheline. On
the day of MDA 120 mosquitoes were caught of which 48
(40.0%) were anopheline. Seventy-six mosquitoes were caught
the following day of which 26 were anopheline (34.2%). On the
ﬁnal day of catching 97 mosquitoes were caught of which 22
(22.6%) were anopheline (Table 1).
The 5-day mortality for pre-MDA anopheline mosquitoes was
25%. The respective 5-day mortalities for anopheline mosqui-
toes caught post-MDA were 75% on day 1, 80% on day 2 and
68% on day 3 (Figure 1). Mortality was signiﬁcantly increased
for mosquitoes caught each of the 3 days post MDA (Table 2).
Mortality was highest in mosquitoes caught on day 1 (HR 4.2,
95% CI 1.8 to 10.1) and day 2 (HR 4.4, 95% CI 1.8 to 10.8). We
also noted increased 5-day mortality of Culex mosquitoes
although the effect size was smaller than that noted for
Anopheles species (Figure 2 and Table 2) No Aedes mosquitoes
were caught during the experiments.
Discussion
In this ﬁeld study we have seen an incidental but signiﬁcant
increase in mortality of Anopheles caught up to 3 days after
ivermectin MDA for scabies control. As ivermectin MDA may be
scaled up for the control of scabies in the Paciﬁc region the inci-
dental impact on mosquitoes is worthy of further study. This
study adds to existing data16,20 and suggests that a single dose
of ivermectin MDA for scabies control could have a possible
impact on the survival rate of Anopheles in the Solomon
Islands, where the main vector can elude control with LLINs
and IRS, and biting rates are comparatively low. While an effect
of ivermectin on An. farauti s.s. has previously been documented
in volunteer-feeding studies, the current study is to our knowl-
edge the ﬁrst ﬁeld study assessing the mortality of An. farauti
s.s. after ivermectin MDA in this area.
Mosquito mortality was higher in those caught within the
ﬁrst 48 hours of MDA and had begun to decline by day 3. This
trend is in line with the known pharmacokinetics of ivermectin
as reduced plasma levels are expected 3 days after a single
200 μg/kg dose.31,32 It has to be noted though that the mortality
rates seen on day 1 and day 2 could have purely been caused
by mosquitoes biting the HLCs only. However, village life did con-
tinue during catches and therefore, the collected mosquitoes
may have represented a mixture of those who feed on catchers
and villagers, with some of the mosquitoes biting villagers as
well as catchers to complete a full blood meal.
The main limitations of this study are the small number of
mosquitoes caught, the limited time frame in which the study
was conducted and the lack of a parallel control site. It was not
possible to do parity dissections to account for previous blood
meals and age distribution of mosquitoes which might have
affected our ﬁndings, as we could not determine the age struc-
ture of our mosquitoes. However, a study conducted in Northern
Guadacanal showed only a seasonal change in density not in age
structure.11 This study was conducted at a time when mosquito
density has previously been reported to on the lower end for
Anopheles mosquitoes.10,13 Despite this the number of anopheline
mosquitoes caught was in line with our target sample size.
Table 1. Species of mosquitoes caught by day
Species Pre-MDA Day of MDA 24 h post-MDA 48 h post-MDA Total
Anopheles 24 (21.8%) 48 (40.0%) 26 (34.2%) 22 (22.6%) 120 (30.2%)
Culex 86 (78.1%) 72 (60.0%) 50 (65.8%) 69 (77.4%) 277 (69.8%)
Total 110 120 76 91 397
MDA: Mass drug administration.
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Although mosquitoes were caught for only a limited number of
hours each day it has been previously documented that the peak
biting period occurs between 18:00 h–21:00 h, which is the time
period chosen for mosquito catches in this study.12
Modeling studies suggest that large scale ivermectin MDA
with an effect size similar to that seen in this study would be
anticipated to result in reductions in malaria transmission.33
Larger ﬁeld studies are needed to conﬁrm this and consideration
should be given to assessing both entomological and clinical
malaria endpoints in other scabies MDA studies in the region. If
conﬁrmed in larger studies this might represent an opportunity
for integration and synergies between vector borne disease and
NTD control programmes.
An. farauti s.s. has indiscriminate host feeding preferences
and will also readily feed on livestock such as pigs. Treatment
of pigs with ivermectin may also be a viable strategy in this
setting where communities live in close proximity to livestock.
In this setting, where vectorial capacity is already relatively
low, the addition of ivermectin MDA solely as a complementary
vector control tool to the already existing ones may facilitate
interruption of transmission and ultimately elimination of mal-
aria in the Solomon Islands. It would be helpful to assess this
possibility and the required number of ivermectin treatments
through future modelling using the available entomological
data.
The effect seen on the 5-day mortality rate in Culex mosqui-
toes warrants further research, as culicine mosquitoes have
been reported to be less susceptible to ivermectin.34,35 As culi-
cines were also not identiﬁed in more detail, it was not possible
to identify speciﬁc species and their susceptibility to ivermectin.
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Table 2. Hazard ratios for 5-day mortality
Mosquito species Day of capturea 5-day mortality
HR (95% CI)b
p-valuec
Anopheles 1 4.2 (1.8 to 10.1) 0.001
2 4.4 (1.8 to 10.8) 0.002
3 3.1 (1.2 to 8.1) 0.018
Culex 1 1.9 (1.3 to 2.9) 0.002
2 1.9 (1.2 to 3.0) 0.004
3 2.3 (1.5 to 3.5) <0.001
HR: Hazards ratio; MDA: Mass drug administration.
a Day of capture in relation to MDA. Day 1 indicates mosquitoes
were caught the evening following MDA.
b Hazard ratios compared to mosquitoes caught pre-MDA.
c Wald Test.
Figure 1. 5-day survival of anopheline mosquitoes. Figure 2. 5-day survival of Culex mosquitoes.
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